Evelo Biosciences Inc
Biotechnology
Healthcare
EVLO
5.58 M shares
NASDAQ US
traded
16 Oct 2023
listed
yes
open
3.15
52 week high
13.31
high
3.21
52 week low
1.33
previous Close
3.12
P/E ratio
-1
market cap
243 M
div yield
0
net incoming
-21.10 M
16.72 %
net profit margin
-2110300000.00 %
0.00 %
operating incoming
-19.57 M
21.39 %
net change in cash
-19.85 M
3.05 %
cash on hand
7.62 M
-72.26 %
cost of revenue
1.62 M
0.00 %
top